S. Evers

A combination of anti-CD3 and anti-CD7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease.

D. Ruiter, H. Spits, T. D. de Witte, 2000, Blood.

Influence of cytotoxicity enhancers in combination with human serum on the activity of CD22-recombinant ricin A against B cell lines, chronic and acute lymphocytic leukemia cells

R. Bongaerts, T. D. Witte, S. Evers, 1999, Leukemia.

A combination of anti-CD 3 and anti-CD 7 ricin A-immunotoxins for the in vivo treatment of acute graft versus host disease

D. Ruiter, H. Spits, F. Preijers, 2022 .

Production of anti-CD3 and anti-CD7 ricin A-immunotoxins for a clinical pilot study.

D. Ruiter, J. Koopman, T. D. de Witte, 2001, International journal of pharmaceutics.

PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma Cancer

C. Punt, J. Schalken, H. van Eenennaam, 2012, Journal of immunotherapy.